ILK Deletion Protects Against Chronic Kidney Disease-Associated Vascular Damage
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010215 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sofía Campillo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Physiology Unit, Department of Systems Biology, Universidad de Alcalá, 28871 Alcalá de Henares, Madrid, Spain. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Protein Serine-Threonine Kinases, Gene Deletion. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Comunidad de Madrid, University of Alcalá.
Abstract (Originalsprache)
Cardiovascular diseases are a major cause of morbidity and mortality in chronic kidney disease (CKD) patients. Integrin-linked kinase (ILK) regulates integrin–extracellular matrix interactions and vascular integrity. This study investigated the role of ILK in CKD-associated vascular alterations. An adenine-supplemented diet induced a progressive CKD in wild-type (WT) and conditional ILK knock-down (cKD-ILK) mice. Aortic tissue was collected for histology and RT-qPCR analysis. Moreover, aortas were incubated ex vivo with the uremic toxins p-cresyl sulfate and indoxyl sulfate. In vitro, human aortic vascular smooth muscle cells were exposed to uremic toxins, and the effect of siRNA-mediated ILK silencing was tested. Aortas of adenine-fed WT mice showed a progressive increase in ILK expression, morphological alterations, and increased fibrosis, which was not observed in cKD-ILK aortas, compared to control mice. Statistically significant correlations between vascular content of ILK and fibrosis markers were observed. Ex vivo, uremic toxins increased ILK and fibrosis protein expression in WT aortas but not in cKD-ILK. In vitro, uremic toxins increased ILK activity and fibrosis markers, like collagen, while ILK-deleted cells prevented collagen increase. ILK depletion prevents CKD-associated vascular fibrosis, suggesting ILK as a potential therapeutic target to prevent arterial alterations in renal patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Physiology Unit, Department of Systems Biology, Universidad de Alcalá, 28871 Alcalá de Henares, Madrid, Spain.
- Fundación Renal Española, 28003 Madrid, Spain.
- Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, Spain.
- INNOREN-CM, 28049 Madrid, Spain.
- RICORS 2040 RENAL, Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Department of Medicine and Medical Specialties, Universidad de Alcalá, 28871 Alcalá de Henares, Madrid, Spain.
ORCID-Profile: Sofía Campillo, Elena Gutiérrez-Calabrés, Susana García-Miranda, Mercedes Griera, Sergio de Frutos, Diego Rodríguez-Puyol, Laura Calleros
Förderung
- Instituto de Salud Carlos III
- Comunidad de Madrid
- University of Alcalá
Zitieren
APA
Campillo, S., Gutiérrez-Calabrés, E., García-Miranda, S., Griera, M., de Frutos, S., Rodríguez-Puyol, D., & Calleros, L. (2025). ILK Deletion Protects Against Chronic Kidney Disease-Associated Vascular Damage. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010215
Vancouver
Campillo S, Gutiérrez-Calabrés E, García-Miranda S, Griera M, de Frutos S, Rodríguez-Puyol D, et al. ILK Deletion Protects Against Chronic Kidney Disease-Associated Vascular Damage. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010215
BibTeX
@article{Campillo2025,
author = {Campillo, Sofía and Gutiérrez-Calabrés, Elena and García-Miranda, Susana and Griera, Mercedes and de Frutos, Sergio and Rodríguez-Puyol, Diego and Calleros, Laura},
title = {ILK Deletion Protects Against Chronic Kidney Disease-Associated Vascular Damage},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010215}
}
EUVIMED